Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.38 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24787748 | 0.92 | GAA (0.44) | GAAPOLBGFERTAAR1MGAM | |
| SCHEMBL12062506 | 0.83 | POLB (0.55) | GAAPOLBGFERTAAR1P2RX3 | |
| SCHEMBL16900309 | 0.83 | POLB (0.46) | GAAPOLBGFERTAAR1P2RX3 | |
| SCHEMBL16200302 | 0.82 | GAA (0.41) | GAAPOLBGFERTAAR1MGAM | |
| SCHEMBL13621572 | 0.80 | TAS1R3 (0.39) | GAA | |
| SCHEMBL1754168 | 0.79 | POLB (0.47) | GAAPOLBGFERTAAR1P2RX3 | |
| SCHEMBL19250261 | 0.79 | GAA (0.43) | GAAPOLBGFERTAAR1P2RX3 | |
| SCHEMBL1753939 | 0.79 | POLB (0.47) | GAAPOLBGFERTAAR1P2RX3 | |
| SCHEMBL20969672 | 0.79 | POLB (0.47) | GAAPOLBGFERTAAR1P2RX3 | |
| SCHEMBL14433087 | 0.77 | TSHR (0.46) | GAAPOLBGFERTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8772290-B2 | Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same | Oscotech Inc. (KR) | 2014-07-08 | — | — | US | disclosed |
| EP-2565180-A2 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Oscotec Inc. (KR) | 2013-03-06 | — | — | EP | disclosed |
| US-20120149707-A1 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | OSCOTEC INC. (KR) | 2012-06-14 | — | — | US | disclosed |
| EP-1818718-A2 | Photothermographic material and method of thermal development of the same | Fuji Photo Film Co., Ltd. (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-7186500-B2 | Silver halide photographic lightsensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7186500-B2 | Silver halide photographic lightsensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7183365-B2 | Electroactive fluorene polymers having perfluoroalkyl groups, process for preparing such polymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| US-7183366-B2 | Aromatic copolymers from dihalofluorene compounds and another dihalo- or diborono- aromatic monomers; organic electroluminescent polymers for use in light-emitting diodes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149707-A1 | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | HIF1A, HIF1AN, EGLN3 | GAA 2071/4885POLB 1442/4885GFER 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.